Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroses, Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Large-scale testing (Phase 3)UnknownNCT04553419
What this trial is testing

Antibiotic Treatment Of Staphylococcus Aureus In Stable People With CF

Who this might be right for
Cystic Fibrosis
University of British Columbia 86
Not applicableStudy completedNCT03797677
What this trial is testing

MN4000 for Treatment of CF and MND Patients in the Home Setting

Who this might be right for
Cystic FibrosisMotor Neuron DiseaseAirway Clearance Impairment
Hill-Rom 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05444257
What this trial is testing

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 822
Large-scale testing (Phase 3)Study completedNCT06383819
What this trial is testing

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Who this might be right for
Post-Acute COVID-19 SyndromeLung Disease With PolymyositisFibrosis+2 more
NPO Petrovax 392
Not applicableLooking for participantsNCT05818319
What this trial is testing

Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy

Who this might be right for
Cystic Fibrosis (CF)CFTR Gene Mutation
University of Aarhus 30
Not applicableStudy completedNCT03318328
What this trial is testing

Evaluation of Food Insecurity in Adults and Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Dixie Durham 87
Not applicableUnknownNCT06251622
What this trial is testing

Muscle Function and Physical Activity in the Modern Era of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Hospices Civils de Lyon 112
Not applicableUnknownNCT01499745
What this trial is testing

Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Rabin Medical Center 40
Not applicableStudy completedNCT00221572
What this trial is testing

Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University Hospital, Ghent 68
Post-approval studies (Phase 4)Study completedNCT01323101
What this trial is testing

Doxycycline Effects on Inflammation in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Southern California 21
Not applicableStudy completedNCT00842465
What this trial is testing

Prolactin Receptor and Breast Diseases

Who this might be right for
Benign Breast DiseaseBreast Cancer
Assistance Publique - Hôpitaux de Paris 735
Not applicableUnknownNCT02827734
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)

Who this might be right for
Pulmonary Healthy ControlsInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+3 more
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Large-scale testing (Phase 3)Study completedNCT01641393
What this trial is testing

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Who this might be right for
Exocrine Pancreatic Insufficiency: Cystic Fibrosis
Forest Laboratories 96
Large-scale testing (Phase 3)Study completedNCT00880100
What this trial is testing

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
Forest Laboratories 49
Post-approval studies (Phase 4)Ended earlyNCT00975663
What this trial is testing

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

Who this might be right for
Lung and Heart-lung Transplantation
University Hospital, Limoges 180
Not applicableUnknownNCT02509364
What this trial is testing

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Who this might be right for
Interstitial Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China 300
Not applicableActive Not RecruitingNCT04680832
What this trial is testing

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 600
Early research (Phase 1)Study completedNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 45
Next Page